Menometrorrhagia in the perimenopause is associated with increased serum estradiol

Maturitas

Volumn 47, Issue 2, 2004, Pages 151-155

  Moen, M H ^a   Kahn, H ^b   Bjerve, K S ^a   Halvorsen, T B ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Ila Medical Center   (Norway)

Author keywords

Endometrium; Menometrorrhagia; Perimenopause; Serum estradiol

Indexed keywords

ESTRADIOL; FOLLITROPIN;

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM HYPERPLASIA; ESTRADIOL BLOOD LEVEL; FEMALE; HISTOLOGY; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; MENOMETRORRHAGIA; MENSTRUAL CYCLE; METRORRHAGIA; ORAL CONTRACEPTION; PROSPECTIVE STUDY;

EID: 1642562991     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00250-0     Document Type: Article

References (14)

1. Seltzer V.L., Benjamin F., Deutsch S. Perimenopausal bleeding patterns and pathologic findings. J. Am. Med. Womens Assoc. 45:1990;132-134.
2. Nilsen S.T., Fredriksen T., Iversen O.E., Moen M.H. Attitude to and practice of Norwegian gynecologists concerning hormone replacement therapy in climacteric. Tidsskr. Nor. Laegeforen. 118:1998;2940-2943.
3. Cornier E. The Pipelle: a disposable device for endometrial biopsy. Am. J. Obstet. Gynecol. 148:1984;109-110.
4. Kirschner R., Nesheim B.I., Urnes A., Langebrekke A., Skar O.J. Examination and treatment of gynecological bleeding disorders. Tidsskr. Nor. Laegeforen. 112:1992;2762-2764.
5. Shideler S.E., De Vane G.W., Kalra P.S., Benirschke K., Lasley B.L. Ovarian pituitary hormone interactions during the perimenopause. Maturitas. 11:1989;331-339.
6. Santoro N., Brown J.R., Adel T., Skurnick J.H. Characterization of reproductive hormonal dynamics in the perimenopause. J. Clin. Endocrinol. Metab. 81:1996;1495-1501.
7. Burger H.G., Dudley E.C., Hopper J.L., et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J. Clin. Endocrinol. Metab. 80:1995;3537-3545.
8. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density, Maturitas 1995;21:103-13.
9. Overlie I., Moen M.H., Morkrid L., Skjaeraasen J.S., Holte A. The endocrine transition around menopause - a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet. Gynecol. Scand. 78:1999;642-647.
10. Welt C.K., McNicholl D.J., Taylor A.E. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J. Clin. Endocrinol. Metab. 84:1999;105-111.
11. Hickey M, Higham, Fraser IS. Progestins versus estrogen and progesterons for irregular uterine bleeding associated with anovulation, In: The Cochrane Library, Issue 1. Oxford: Update Software, 2001 (Cochrane Review).
12. Saarikoski S., Yliskoski M., Penttila I. Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders. Maturitas. 12:1990;89-97.
13. Davis A., Godwin A., Lippman J., Olson W., Kafrissen M. Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding. Obstet. Gynecol. 96:2000;913-920.
14. Thomas E.J., Okuda K.J., Thomas N.M. The combination of a depot gonadotrophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding. Br. J. Obstet. Gynaecol. 98:1991;1155-1159.